Hämäläinen Tuula, Kero Jukka, Poutanen Matti, Huhtaniemi Ilpo
Department of Physiology, University of Turku, Finland.
Endocrinology. 2002 Oct;143(10):4096-103. doi: 10.1210/en.2002-220162.
In vivo regulation of the LH receptor (LHR) promoter was studied using transgenic (TG) mice harboring fusion genes containing three different lengths of the LHR promoter (7.4 kb, 2.1 kb, and 173 bp), fused with coding sequence of the Escherichia coli beta-galactosidase (beta-GAL) reporter gene. The length of the LHR promoter significantly affected the pattern of beta-GAL expression. In the testis the shortest promoter directed expression primarily of the full-length beta-GAL mRNA, but mainly truncated messages were transcribed from the longer LHR promoter/beta-GAL constructs. The case was reversed in the ovary and adrenal gland. Furthermore, we have recently detected strong LHR expression in the adrenal gland of female mice with chronically elevated serum LH. Therefore, the regulation of the adrenal LHR expression was addressed in the present study using the LHR/beta-GAL TG mice. Elevated LH levels were achieved in the LHR/beta-GAL mice either by gonadectomy or cross-breeding them with TG mice overexpressing a chimeric protein of bovine LH beta-subunit and the C-terminal fragment of human chorionic gonadotropin-beta. In both models, beta-GAL mRNA was found in the adrenal cortex when the 7.4-kb LHR promoter was applied but not in mice carrying the 173-bp LHR promoter. The 7.4-kb construct was activated also in the ovaries in the double TG LHR(beta-GAL)/bovine LH beta-subunit/C-terminal fragment of human chorionic gonadotropin-betamice in some theca-interstitial cells surrounding the follicles. Hence, the LHR promoter elements essential for directing beta-GAL expression to the adrenal gland and ovary (7.4 kb) are different from those recently shown to be essential for the testicular expression (173 bp). In conclusion, elevated serum LH concentrations were found seminal for the LHR promoter activation in the ovaries and adrenals, and different lengths of the promoter are responsible for reporter gene expression in the testis, ovary, and adrenal gland.
利用携带融合基因的转基因(TG)小鼠研究促黄体生成素受体(LHR)启动子的体内调控,这些融合基因包含三种不同长度的LHR启动子(7.4 kb、2.1 kb和173 bp),并与大肠杆菌β-半乳糖苷酶(β-GAL)报告基因的编码序列融合。LHR启动子的长度显著影响β-GAL的表达模式。在睾丸中,最短的启动子主要指导全长β-GAL mRNA的表达,但从较长的LHR启动子/β-GAL构建体转录的主要是截短的信息。在卵巢和肾上腺中情况则相反。此外,我们最近在血清促黄体生成素长期升高的雌性小鼠的肾上腺中检测到强烈的LHR表达。因此,本研究使用LHR/β-GAL TG小鼠探讨肾上腺LHR表达的调控。通过性腺切除术或与过表达牛促黄体生成素β亚基和人绒毛膜促性腺激素β C末端片段的嵌合蛋白的TG小鼠杂交,使LHR/β-GAL小鼠的促黄体生成素水平升高。在这两种模型中,当应用7.4 kb的LHR启动子时,在肾上腺皮质中发现了β-GAL mRNA,但在携带173 bp LHR启动子的小鼠中未发现。在双转基因LHR(β-GAL)/牛促黄体生成素β亚基/人绒毛膜促性腺激素β C末端片段小鼠的卵巢中,围绕卵泡的一些卵泡膜间质细胞中,7.4 kb构建体也被激活。因此,将β-GAL表达导向肾上腺和卵巢(7.4 kb)所必需的LHR启动子元件与最近显示对睾丸表达至关重要的元件(173 bp)不同。总之,发现血清促黄体生成素浓度升高对卵巢和肾上腺中LHR启动子的激活至关重要,并且不同长度的启动子负责报告基因在睾丸、卵巢和肾上腺中的表达。